Previous 10 | Next 10 |
2024-06-26 04:35:00 ET Pharma giant Eli Lilly (NYSE: LLY) has become an unstoppable stock to own lately. Year to date, its share price is up more than 50%. And despite trading at a hefty 130 times earnings, investors continue to buy up more shares of the company. Although it may s...
2024-06-26 03:33:34 ET More on Eli Lilly, Vigil Neuroscience, etc. Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress ResM...
2024-06-25 17:50:06 ET Summary Roche Holding AG stock has seen a 13% price rise in the past month following positive trial results for its obesity treatment. Weight management and associated diseases like diabetes have huge potential, as seen from the examples of Novo Nordisk and ...
A look at the top 10 most actives in Canada TC Energy Corporation (TRP) rose 0.2% to $53.5 on volume of 22,020,828 shares Fission Uranium Corp. (FCU) rose 0.0% to $1.19 on volume of 19,601,007 shares Victoria Gold Corp. (VGCX) fell 81.7% to $1.36 on volume of 15,148,780 shares Whitecap ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 6.8% to $126.09 on volume of 414,790,976 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 18.7% to $0.265 on volume of 162,165,405 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 12.6%...
2024-06-25 13:37:45 ET More on Eli Lilly, ResMed, etc. Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Lilly gains appr...
2024-06-25 13:15:54 ET More on Novo Nordisk Novo Nordisk: Leading The Fight Against Diabetes And Obesity Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk's Wegovy ge...
2024-06-25 12:12:34 ET More on Eli Lilly Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Eli Lilly collaborates with Op...
2024-06-25 11:08:09 ET Eli Lilly and Company ( NYSE: LLY ) said on Tuesday that it is collaborating with Microsoft ( MSFT ) backed-OpenAI that will help leverage generative AI to invent novel antimicrobials to treat drug-resistant pathogens.... Read the full article on See...
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria PR Newswire INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Zoomcar Holdings Inc. (ZCAR) rose 58.3% to $0.2162 on volume of 130,087,791 shares Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.1863 on volume of 71,767,970 shares SMX (Security Matters) Public Limited Company (SMX) rose 17.1...
2024-07-02 16:00:05 ET Terence Flynn from Morgan Stanley issued a price target of $1,023.00 for LLY on 2024-07-02 14:30:00. The adjusted price target was set to $1,023.00. At the time of the announcement, LLY was trading at $906.1521. The overall price target consensus i...
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participan...